Comments on the guidelines of the European Malignant Hyperthermia Group on the availability of dantrolene for the management of malignant hyperthermia crises

被引：0
|
作者：
Bastian, B. [1 ]
Heiderich, S. [2 ]
Schuster, F. [3 ]
Johannsen, S. [3 ]
Klingler, W. [4 ]
Rueffert, H. [5 ]
机构：
[1] Univ Klinikum Leipzig AoR, Zentrum Maligne Hyperthermie, Klin & Poliklin Anasthesiol & Intens Therapie, Liebigstr 20, D-04103 Leipzig, Germany
[2] Hannover Med Sch, Zentrum Maligne Hyperthermie, Klin Anasthesiol & Intens Med, Hannover, Germany
[3] Univ Klinikum Wurzburg, Zentrum Maligne Hyperthermie, Klin & Poliklin Anasthesiol Intens Med & Schmerzt, Wurzburg, Germany
[4] SRH Kliniken Landkreis Sigmaringen, Klin Anasthesie & Intens Med, Sigmaringen, Germany
[5] Helios Klin Schkeuditz, Klin Anasthesie Intens Med & Schmerztherapie, Schkeuditz, Germany
来源：
ANAESTHESIST | 2020年 / 69卷 / 10期
关键词：
Succinylcholin; Volatile Anästhetika; Inhalative Sedierung; Ambulante Anästhesie; Notfallmedizin;
D O I：
10.1007/s00101-020-00839-x
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
[No abstract available]
引用
收藏
页码：751 / 752
页数：2
相关论文
共 50 条
  • [1] Availability of dantrolene for the management of malignant hyperthermia crises: European Malignant Hyperthermia Group guidelines
    Glahn, Klaus P. E.
    Bendixen, Diana
    Girard, Thierry
    Hopkins, Philip M.
    Johannsen, Stephan
    Rueffert, Henrik
    Snoeck, Marc M.
    Urwyler, Albert
    BRITISH JOURNAL OF ANAESTHESIA, 2020, 125 (02) : 133 - 140
  • [2] Kommentar zur Leitlinie der European Malignant Hyperthermia Group zur Verfügbarkeit von Dantrolen für die Behandlung der Malignen HyperthermieComments on the guidelines of the European Malignant Hyperthermia Group on the availability of dantrolene for the management of malignant hyperthermia crises
    B. Bastian
    S. Heiderich
    F. Schuster
    S. Johannsen
    W. Klingler
    H. Rüffert
    Der Anaesthesist, 2020, 69 : 751 - 752
  • [3] Malignant Hyperthermia and Pregnancy Guidelines of the European Malignant Hyperthermia Group
    Schuster, Frank
    Johannsen, Stephan
    ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2021, 56 (05): : 367 - 372
  • [4] European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility
    Hopkins, P. M.
    Rueffert, H.
    Snoeck, M. M.
    Girard, T.
    Glahn, K. P. E.
    Ellis, F. R.
    Mueller, C. R.
    Urwyler, A.
    BRITISH JOURNAL OF ANAESTHESIA, 2015, 115 (04) : 531 - 539
  • [5] The European Malignant Hyperthermia Group consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients
    Heiderich, Sebastian
    Bastian, Borge
    Johannsen, Stephan
    Klingler, Werner
    Ruffert, Henrik
    Schuster, Frank
    ANAESTHESIST, 2021, 70 (02): : 155 - 157
  • [6] Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group
    Glahn, K. P. E.
    Ellis, F. R.
    Halsall, P. J.
    Mueller, C. R.
    Snoeck, M. M. J.
    Urwyler, A.
    Wappler, F.
    BRITISH JOURNAL OF ANAESTHESIA, 2010, 105 (04) : 417 - 420
  • [7] Consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients from the European Malignant Hyperthermia Group
    Rueffert, Henrik
    Bastian, Boerge
    Bendixen, Diana
    Girard, Thierry
    Heiderich, Sebastian
    Hellblom, Anna
    Hopkins, Philip M.
    Johannsen, Stephan
    Snoeck, Marc M.
    Urwyler, Albert
    Glahn, Klaus P. E.
    BRITISH JOURNAL OF ANAESTHESIA, 2021, 126 (01) : 120 - 130
  • [8] DANTROLENE AND MALIGNANT HYPERTHERMIA
    GROTE, B
    ANAESTHESIST, 1982, 31 (05): : 211 - 212
  • [9] DANTROLENE IN MALIGNANT HYPERTHERMIA
    BERNSTEIN, LR
    DAVIS, LJ
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1979, 13 (01): : 40 - 40
  • [10] DANTROLENE AND MALIGNANT HYPERTHERMIA
    DOLAN, PF
    ANESTHESIOLOGY, 1982, 57 (03) : 246 - 247
12345